Showing results (151-160 of 192) with videos related to
Sort By:
Pageof 20
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 19, 2012
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotypeChung-Feng Huang, Ming-Lung Yu, Jia-Horng Kao, et al.Medicine|March 11, 2016
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C InfectionWan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, et al.Hepatology (Baltimore, Md.)|November 1, 2012
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversionHung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, et al.The Journal of Clinical Investigation|January 9, 2018
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuationLaura Rivino, Nina Le Bert, Upkar S Gill, et al.Journal of Movement Disorders|March 6, 2023
Clinical Characteristics, Genetic Features, and Long-Term Outcome of Wilson's Disease in a Taiwanese Population: An 11-Year Follow-Up StudySung-Pin Fan, Yih-Chih Kuo, Ni-Chung Lee, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2008
Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trialChen-Hua Liu, Chun-Jen Liu, Chih-Lin Lin, et al.Gut|April 26, 2014
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 29, 2024
Fibrosis-4 index stratifies risks of hepatocellular carcinoma in patients with chronic hepatitis CShan-Han Chang, Tung-Hung Su, Ze-Min Ling, et al.Gastroenterology|August 31, 2019
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral LoadTai-Chung Tseng, Chun-Jen Liu, Chen-Yang Hsu, et al.The Journal of Infectious Diseases|May 13, 2020
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing ChemotherapyWei-Yuan Chang, Yen-Cheng Chiu, Fang-Wei Chiu, et al.Pageof 20